शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BLUESTARCOBSEBLUE STAR LIMITED· Consumer DurablesMediumNeutral
Announced Thu, 29 Oct, 2026 · 16:13 IST

Q2 sales and PAT rise, but exceptional gains mask weaker standalone profit

Revenue growth above 20%Profit growth above 25%Exceptional itemResults View source PDFExplain this filing

BLUESTARCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.7%Reaction day
₹1673.00
prior close
₹1633.40
announcement price
After-mkt
timing
Nifty Midcap 150market-0.9%-1.8% vs market
Household Appliances peers, median of 23sector-2.6%-0.1% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Midcap 150 and 0.1 pts less than its Household Appliances peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.5
10m
-3.1
15m
-2.8
30m
-2.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.7-0.9-1.8-2.6-0.1
Next day
-4.7+0.3-5.0-1.3-3.4
2d
-6.4+1.3-7.8-0.2-6.2
3d
-7.3+2.9-10.2+0.4-7.7
4d
-6.0+4.9-10.9+0.9-6.9
5d
-5.9pendingpending+2.8-8.6
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Midcap 150Sector · Household Appliances peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Blue Star approved unaudited Q2 and H1 FY2027 results. Consolidated Q2 revenue rose 21.0% year on year to 2,930.95 crore and PAT rose 25.4% to 123.91 crore; EPS was 6.03. H1 revenue rose 16.7% to 6,308.87 crore, but PAT rose only 3.1% to 226.42 crore. The Q2 operating EBITDA margin fell to 6.91% from 7.57%. H1 included 32.19 crore of exceptional gains from Medtech and property sales. Standalone H1 PAT fell about 42% to 107.60 crore.

Likely market impact

Higher sales and headline profit support sentiment, but margin compression and exceptional gains make the improvement less sustainable.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹2,931 Cr₹2,422 Cr+21.0%
Operating profit₹117.8 Cr₹123.1 Cr−4.3%
Profit after tax₹123.9 Cr₹98.78 Cr+25.4%
EBITDA margin7.7%7.6%+0.1 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.